You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

April 22, 2011

Clemence Gautier to Speak on Clinical Trials

Subscribe to Updates

On May 20, 2011, Clemence Gautier, Consultant, Intellectual Property, will speak at what has been billed as the most comprehensive forum on clinical trials in Thailand. Clinical Trial Forum Thailand 2011 aims to assemble key opinion leaders from the government, research institutes, service providers, originators, and other stakeholders to discuss contemporary challenges in the Thailand market.

Clemence Gautier will present on “Overcoming Regulatory and Patent Roadblocks for Clinical Trials in Asia: Thailand and Vietnam,” which will provide practical tips for ensuring smooth clinical trials in Thailand, from both a regulatory and a contractual perspective. For more information on Clinical Trial Forum Thailand 2011, access the Lawson-Marsh website.

RELATED PROFESSIONAL

Industries

Life Sciences

Practices

Intellectual Property

Regulatory Affairs

Location

RELATED INSIGHTS​ 

November 29, 2019
Asia Business Law Journal  recently released the 2019 edition of The A-List: Thailand’s Top 100 Lawyers, an annual publication that shines the spotlight on 100 of the most highly regarded private practice lawyers in the jurisdiction. In line with the release of the publication, Tilleke & Gibbins is proud to share that eight of the firm’s practitioners have been recognized as some of Thailand’s leading attorneys, including:
Read More
September 17, 2019
Tilleke & Gibbins has further cemented its top position in Thailand in Asialaw Profiles 2020 , a highly regarded survey of Asia-Pacific’s leading regional and domestic law firms. The guide ranks firms in nine practice areas and nine industry sectors in Thailand, and Tilleke & Gibbins once again earned rankings in all 18 areas—more than any other firm. For 12 of these categories, Tilleke & Gibbins was placed in the highest tier awarded (marked by asterisks in the table below).
Read More